API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one
2. Ebc-46
1. Ebc-46
2. Ebi-46
3. Tigilanol Tiglate [usan]
4. 943001-56-7
5. R1zjt87990
6. 12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tiglian-3-one
7. (4s,5s,6r,7s,8r,9r,10s,11r,12r,13s,14r)-12-(2e)-2-methyl-2-enoatyl-13((2s)-2-methylbutyroyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one
8. Unii-r1zjt87990
9. Tigilanol Tiglate [mi]
10. Tigilanol Tiglate (usan/inn)
11. Tigilanol Tiglate [inn]
12. Chembl3989916
13. Dtxsid601029530
14. Tigilanol Tiglate [who-dd]
15. D11191
16. (1ar,1br,1cs,2ar,3s,3as,6as,6br,7r,8r,8as)-3,3a,6b-trihydroxy-2a-(hydroxymethyl)-1,1,5,7-tetramethyl-4-oxo-1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-8ah-cyclopropa(5',6')benzo(1',2':7,8)azuleno(5,6-b)oxirene-8,8a-diyl 8a-((2s)-2-methylbutanoate) 8-((2e)-2-methylbut-2-enoate)
Molecular Weight | 562.6 g/mol |
---|---|
Molecular Formula | C30H42O10 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 562.27779753 g/mol |
Monoisotopic Mass | 562.27779753 g/mol |
Topological Polar Surface Area | 163 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 1220 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of non-resectable, non-metastatic (WHO staging) subcutaneous mast cell tumours located at or distal to the elbow or the hock, and non-resectable, non metastatic cutaneous mast cell tumours in dogs.
QL01XX